APOC3 / Apolipoprotein C III Antibody
Goat Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| IHC-P, E |
---|---|
Primary Accession | P02656 |
Reactivity | Human |
Host | Goat |
Clonality | Polyclonal |
Calculated MW | 11kDa |
Dilution | IHC-P (3-6 µg/ml) |
Gene ID | 345 |
---|---|
Other Names | Apolipoprotein C-III, Apo-CIII, ApoC-III, Apolipoprotein C3, APOC3 |
Target/Specificity | Human APOC3 / Apolipoprotein CIII. |
Reconstitution & Storage | Store at -20°C. Minimize freezing and thawing. |
Precautions | APOC3 / Apolipoprotein C III Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | APOC3 |
---|---|
Function | Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma. Plays a multifaceted role in triglyceride homeostasis. Intracellularly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion; extracellularly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs). Impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic uptake of TRLs by remnant receptors. |
Cellular Location | Secreted |
Tissue Location | Liver.. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abgent.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma. Plays a multifaceted role in triglyceride homeostasis. Intracellularly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion; extracellularly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs). Impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic uptake of TRLs by remnant receptors.
References
Protter A.A.,et al.DNA 3:449-456(1984).
Levy-Wilson B.,et al.DNA 3:359-364(1984).
Karathanasis S.K.,et al.J. Lipid Res. 26:451-456(1985).
Sharpe C.R.,et al.Nucleic Acids Res. 12:3917-3932(1984).
Fullerton S.M.,et al.Hum. Genet. 115:36-56(2004).

If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.